Mulligan D - Search Results

1

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.

Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Guo L, et al. Among authors: mulligan d. Liver Transpl. 2006 Apr;12(4):560-5. doi: 10.1002/lt.20660. Liver Transpl. 2006. PMID: 16555313 Free article.

2

Should liver transplantation be performed for hepatitis B?

Mulligan DC, Klintmalm GB. Mulligan DC, et al. Clin Transplant. 1995 Jun;9(3 Pt 2):246-8. Clin Transplant. 1995. PMID: 7670170 Review. No abstract available.

3

A comparison of treatment with transjugular intrahepatic portosystemic shunt or distal splenorenal shunt in the management of variceal bleeding prior to liver transplantation.

Abouljoud MS, Levy MF, Rees CR, Diamond NG, Lee SP, Mulligan DC, Goldstein RM, Husberg B, Gonwa TA, Klintmalm GB. Abouljoud MS, et al. Among authors: mulligan dc. Transplantation. 1995 Jan 27;59(2):226-9. Transplantation. 1995. PMID: 7839445 Clinical Trial.

4

Use of anti-hepatitis C virus seropositive organs in liver transplantation.

Mulligan DC, Goldstein RM, Crippin JS, Abouljoud MS, Levy MF, Husberg BS, Gonwa TA, Foster BR, Tillery GW, Klintmalm GB. Mulligan DC, et al. Transplant Proc. 1995 Feb;27(1):1204-5. Transplant Proc. 1995. PMID: 7878850 Clinical Trial. No abstract available.

5

A randomized, prospective, double-blinded evaluation of selective bowel decontamination in liver transplantation.

Hellinger WC, Yao JD, Alvarez S, Blair JE, Cawley JJ, Paya CV, O'Brien PC, Spivey JR, Dickson RC, Harnois DM, Douglas DD, Hughes CB, Nguyen JH, Mulligan DC, Steers JL. Hellinger WC, et al. Among authors: mulligan dc. Transplantation. 2002 Jun 27;73(12):1904-9. doi: 10.1097/00007890-200206270-00009. Transplantation. 2002. PMID: 12131685 Clinical Trial.

6

Detection of hepatitis C virus sequences in brain tissue obtained in recurrent hepatitis C after liver transplantation.

Vargas HE, Laskus T, Radkowski M, Wilkinson J, Balan V, Douglas DD, Harrison ME, Mulligan DC, Olden K, Adair D, Rakela J. Vargas HE, et al. Among authors: mulligan dc. Liver Transpl. 2002 Nov;8(11):1014-9. doi: 10.1053/jlts.2002.36393. Liver Transpl. 2002. PMID: 12424714 Free article.

7

Amelioration of hepatic ischemia/reperfusion injury using indolepropionic acid.

Lefler SR, St Peter SD, Rodriguez-Davalos MI, Perumean JC, Spence NA, Moss AA, Mulligan DC. Lefler SR, et al. Among authors: mulligan dc. Transplant Proc. 2002 Dec;34(8):3065-6. doi: 10.1016/s0041-1345(02)03616-3. Transplant Proc. 2002. PMID: 12493376 No abstract available.

8

Effects of tacrolimus on ischemia-reperfusion injury.

St Peter SD, Moss AA, Mulligan DC. St Peter SD, et al. Among authors: mulligan dc. Liver Transpl. 2003 Feb;9(2):105-16. doi: 10.1053/jlts.2003.50020. Liver Transpl. 2003. PMID: 12548502 Free article. Review.

9

Tacrolimus as a liver flush solution to ameliorate the effects of ischemia/reperfusion injury following liver transplantation.

St Peter SD, Post DJ, Rodriguez-Davalos MI, Douglas DD, Moss AA, Mulligan DC. St Peter SD, et al. Among authors: mulligan dc. Liver Transpl. 2003 Feb;9(2):144-9. doi: 10.1053/jlts.2003.50018. Liver Transpl. 2003. PMID: 12548508 Free article. Clinical Trial.

10

Recent advances in liver transplantation.

Wiesner RH, Rakela J, Ishitani MB, Mulligan DC, Spivey JR, Steers JL, Krom RA. Wiesner RH, et al. Mayo Clin Proc. 2003 Feb;78(2):197-210. doi: 10.4065/78.2.197. Mayo Clin Proc. 2003. PMID: 12583530 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

241 results

Search Page

Filters